YaoGeJu

Company directoryChina company filings

Tianjin Jinjin Pharmaceutical Co., Ltd.

As of 18 November 2026, for the company name Tianjin Jinjin Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 1 active record with this name as holder; 18 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

13 acceptance records as first applicant, grouped into 10 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Budesonide Gastro-Resistant Capsules 1 records · Latest accepted 2026/11/13

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602812Generic2026/11/13Tianjin Jinjin Pharmaceutical Co., Ltd.CDE ↗
Methylprednisolone Tablets 1 records · Latest accepted 2026/10/26

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602621Generic2026/10/26Tianjin Jinjin Pharmaceutical Co., Ltd.CDE ↗
Dexamethasone Acetate Tablets 2 records · Latest accepted 2026/02/27

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2650067Supplement2026/02/27Tianjin Jinjin Pharmaceutical Co., Ltd.CDE ↗
CYHB2100386Supplement2021/04/16Tianjin Jinjin Pharmaceutical Co., Ltd.CDE ↗
Prednisolone Tablets 2 records · Latest accepted 2025/05/13

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2550187Supplement2025/05/13Tianjin Jinjin Pharmaceutical Co., Ltd.CDE ↗
CYHB2100388Supplement2021/04/16Tianjin Jinjin Pharmaceutical Co., Ltd.CDE ↗
倍他米松片 · No verified English name 1 records · Latest accepted 2021/04/16

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2100385Supplement2021/04/16Tianjin Jinjin Pharmaceutical Co., Ltd.CDE ↗
Hydrocortisone Tablets 2 records · Latest accepted 2021/04/16

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2100395Supplement2021/04/16Tianjin Jinjin Pharmaceutical Co., Ltd.CDE ↗
CYHB2100394Supplement2021/04/16Tianjin Jinjin Pharmaceutical Co., Ltd.CDE ↗
醋酸可的松片 · No verified English name 1 records · Latest accepted 2021/04/16

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2100389Supplement2021/04/16Tianjin Jinjin Pharmaceutical Co., Ltd.CDE ↗
醋酸氢化可的松片 · No verified English name 1 records · Latest accepted 2021/04/16

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2100397Supplement2021/04/16Tianjin Jinjin Pharmaceutical Co., Ltd.CDE ↗
醋酸泼尼松片 · No verified English name 1 records · Latest accepted 2021/04/16

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2100387Supplement2021/04/16Tianjin Jinjin Pharmaceutical Co., Ltd.CDE ↗
醋酸泼尼松龙片 · No verified English name 1 records · Latest accepted 2021/04/16

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2100396Supplement2021/04/16Tianjin Jinjin Pharmaceutical Co., Ltd.CDE ↗

Changes in the last 90 days

2 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Accepted: 2 applications

  1. 2026/11/13Accepted

    Budesonide Gastro-Resistant Capsules

    CYHS2602812

    Fact date: 2026/11/13 · Date added to this site: 2026/11/14

    View source ↗
  2. 2026/10/26Accepted

    Methylprednisolone Tablets

    CYHS2602621

    Fact date: 2026/10/26 · Date added to this site: 2026/10/27

    View source ↗

Under review

3 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Budesonide Gastro-Resistant Capsules CYHS2602812Generic2026/11/13Tianjin Jinjin Pharmaceutical Co., Ltd.CDE ↗
Methylprednisolone Tablets CYHS2602621Generic2026/10/26Tianjin Jinjin Pharmaceutical Co., Ltd.CDE ↗
Dexamethasone Acetate Tablets CYHB2650067Supplement2026/02/27Tianjin Jinjin Pharmaceutical Co., Ltd.CDE ↗

Catalogue holder records

1 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Prednisolone TabletsTianjin Jinjin Pharmaceutical Co., Ltd.Tianjin Jinjin Pharmaceutical Co., Ltd.国药准字H310206052026/04/13Drug that passed quality-and-efficacy consistency evaluationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

18 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
甲泼尼龙 · No verified English nameTianjin Jinjin Pharmaceutical Co., Ltd.Y20260000804I2026/10/19CDE ↗
糠酸莫米松一水合物 · No verified English nameTianjin Jinjin Pharmaceutical Co., Ltd.Y20260000071I2026/04/09CDE ↗
盐酸阿扎司琼 · No verified English nameTianjin Jinjin Pharmaceutical Co., Ltd.Y20250001415I2025/12/26CDE ↗
丙酸倍氯米松 · No verified English nameTianjin Jinjin Pharmaceutical Co., Ltd.Y20250001071I2025/10/15CDE ↗
氢化可的松琥珀酸钠 · No verified English nameTianjin Jinjin Pharmaceutical Co., Ltd.Y20250000227A2026/09/04CDE ↗
盐酸阿扎司琼 · No verified English nameTianjin Jinjin Pharmaceutical Co., Ltd.Y20220000590I2024/01/11CDE ↗
氢化可的松 · No verified English nameTianjin Jinjin Pharmaceutical Co., Ltd.Y20220000317A2024/02/08CDE ↗
泼尼松 · No verified English nameTianjin Jinjin Pharmaceutical Co., Ltd.Y20190002948A2025/05/08CDE ↗
醋酸可的松 · No verified English nameTianjin Jinjin Pharmaceutical Co., Ltd.Y20190002947A2025/05/08CDE ↗
醋酸泼尼松 · No verified English nameTianjin Jinjin Pharmaceutical Co., Ltd.Y20190002943A2025/05/08CDE ↗
泼尼松龙 · No verified English nameTianjin Jinjin Pharmaceutical Co., Ltd.Y20190002938A2025/05/08CDE ↗
地塞米松 · No verified English nameTianjin Jinjin Pharmaceutical Co., Ltd.Y20190002935A2025/05/08CDE ↗
丙酸氯倍他索 · No verified English nameTianjin Jinjin Pharmaceutical Co., Ltd.Y20190002898A2025/05/08CDE ↗
醋酸氢化可的松 · No verified English nameTianjin Jinjin Pharmaceutical Co., Ltd.Y20190002866A2025/05/08CDE ↗
地塞米松磷酸钠 · No verified English nameTianjin Jinjin Pharmaceutical Co., Ltd.Y20190002865A2025/05/08CDE ↗
醋酸地塞米松 · No verified English nameTianjin Jinjin Pharmaceutical Co., Ltd.Y20190002864A2025/05/08CDE ↗
氢化可的松 · No verified English nameTianjin Jinjin Pharmaceutical Co., Ltd.Y20190002862A2025/05/08CDE ↗
螺内酯 · No verified English nameTianjin Jinjin Pharmaceutical Co., Ltd.Y20190002855A2025/05/08CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.